1 | Examination Report | 19 Jun 2001 |
1 | Journal Copy | 19 Jun 2001 |
10 | TM-12 | 06 Jun 2011 |
11 | TM-R(RENEWAL OF TRADE MARK) | 02 Jun 2021 |
2 | Reply to Exam Report (MIS-R) | 19 Jun 2001 |
2 | TM-1 | 19 Jun 2001 |
3 | Examination Report | 19 Jun 2001 |
3 | Power of Attorney | 19 Jun 2001 |
3 | Reply to Exam Report (MIS-R) | 19 Jun 2001 |
4 | Additional Representation Sheet | 19 Jun 2001 |
5 | Certificate | 19 Jun 2001 |
6 | Examination Report | 19 Jun 2001 |
6 | TM-1 | 19 Jun 2001 |
7 | Journal Copy | 19 Jun 2001 |
7 | Note Sheet | 19 Jun 2001 |
8 | Note Sheet | 19 Jun 2001 |
8 | Power of Attorney | 19 Jun 2001 |
9 | TM-12 | 24 May 2011 |
1 | O3 NOTICE | 11173240 | 5133649 | 26 Feb 2021 |
2 | RENEWAL INTIMATION LETTER | 11601506 | 06 Jun 2021 |
The application for Dulatine was made on 19 June 2001.
The trademark applicant for Dulatine is EMCURE PHARMACEUTICALS.
Dulatine is applied in class(es) 5.
Application for Dulatine is on Registered stage.
Application Id allotted to Dulatine is 1018439.
Trademark agent or attorney for the application is Aditya & Associates.
Dulatine filed with the Intellectual property office as a WORD.